Medical Devices US

US Preeclampsia Diagnostics Market Analysis, 2024–2034

US Preeclampsia Diagnostics Market Industry Trends and Forecast to 2034: Segmented by (Test, Use, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $691.7 Mn Estimated value
Estimate 2025 $724.9 Mn 45.2% of the global market
Projected 2034 $1.11 Bn 52.5% Adds $380.5 Mn over 9 forecast years
CAGR 2025–2034 4.8% Faster than 25% of 173 Medical Devices markets here
Key players 5
  • US is 45.22% of the global market.
  • In North America, the largest is US (this report) at $724.9 Mn.
  • Fastest growing: Canada at 6.7% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$380.5 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Preeclampsia Diagnostics Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $691.7 Mn — —
2025 (base) $724.9 Mn +$33.2 Mn —
2026 (forecast) $759.7 Mn +$34.8 Mn +4.8%
2027 (forecast) $796.1 Mn +$36.5 Mn +9.8%
2028 (forecast) $834.4 Mn +$38.2 Mn +15.1%
2029 (forecast) $874.4 Mn +$40.0 Mn +20.6%
2030 (forecast) $916.4 Mn +$42.0 Mn +26.4%
2031 (forecast) $960.4 Mn +$44.0 Mn +32.5%
2032 (forecast) $1.01 Bn +$46.1 Mn +38.8%
2033 (forecast) $1.05 Bn +$48.3 Mn +45.5%
2034 (forecast) $1.11 Bn +$50.6 Mn +52.5%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $1.60 Bn
  2. US (this report) $724.9 Mn
  3. North America $725.3 Mn
  4. APAC $325.9 Mn
  5. Europe $285.6 Mn
  6. Canada $131.7 Mn
  7. China $114.6 Mn
  8. Japan $107.0 Mn
  9. Latin America $66.5 Mn
  10. Middle East $64.3 Mn
  11. Germany $56.7 Mn
  12. Brazil $43.0 Mn
  13. France $41.0 Mn
  14. Italy $38.1 Mn
  15. UK $35.6 Mn
  16. Spain $34.6 Mn
  17. India $33.5 Mn
  18. Ecuador $30.7 Mn
  19. Saudi Arabia $28.8 Mn
  20. Mexico $23.4 Mn
  21. Africa $23.1 Mn
  22. Russia $18.2 Mn
  23. New Zealand $17.1 Mn
  24. Australia $17.6 Mn
  25. South Africa $9.6 Mn
  26. UAE $7.4 Mn
  27. Egypt $5.1 Mn
  28. Philippines $3.9 Mn
  29. Malaysia $2.4 Mn
  30. Hong Kong $2.2 Mn
  31. Singapore $2.2 Mn
  32. Thailand $1.7 Mn
  33. Kenya $1.3 Mn

The US Preeclampsia Diagnostics Market Analysis Executive Summary

Preeclampsia diagnostics are blood tests and monitoring tools that predict or detect dangerous high blood pressure in pregnancy.

Key segments of the preeclampsia Diagnostics market include test (sFlt-1/PlGF Ratio Tests, PlGF Tests and Blood Pressure Monitoring) and use (Screening, Diagnosis and Prognosis).

US Preeclampsia Diagnostics Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the preeclampsia Diagnostics market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the preeclampsia Diagnostics market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the preeclampsia Diagnostics market.

Competitive Landscape for Preeclampsia Diagnostics Market in US

The preeclampsia Diagnostics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Preeclampsia Diagnostics Market in US

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how preeclampsia Diagnostics products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Preeclampsia Diagnostics right now, from free public sources.

Latest research 7,556 papers since 2021 (worldwide)

  1. Artificial Intelligence in Obstetrics and Prenatal Medicine: Current Evidence, Clinical Validation and Implementation. Geburtshilfe und Frauenheilkunde, 2026
  2. Skinfolds in nulliparous women and their association with pregnancy complications: a multicenter cohort study in Brazil. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2026
  3. Perinatal outcomes after implementation of a blended virtual and in-person prenatal care model in integrated healthcare systems. Pregnancy (Hoboken, N.J.), 2026
  4. Screening of oxidative stress-related signature genes and construction of an interpretable discriminant model for preeclampsia. Frontiers in genetics, 2026
  5. Blood pressure changes across pregnancy and postpartum: from physiological adaptations to pathological deviations. Frontiers in cardiovascular medicine, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Preeclampsia Diagnostics in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

Questions, answered with public data

How many clinical trials on Preeclampsia Diagnostics are running in the US?
76 studies are recruiting, active or about to start in the US.[4]
How much research is published on Preeclampsia Diagnostics?
PubMed lists 7,556 papers added since January 2021 that match this market, worldwide.[5]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in the US. Retrieved 12 Nov 2026.

[5] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Preeclampsia Diagnostics in US? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Iron Supplements and the Fight Against AnaemiaIron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in US

See all
Same topic, other categories

Related on maternal and diagnostics and lab testing

See the topic